• Profile
Close

The efficacy and safety of trehalose in primary trabeculectomy with mitomycin C: A report of early findings

Clinical Ophthalmology Jun 04, 2021

Sen E, Elgin U, Ozen O, et al. - This retrospective study compared the bleb morphology and tear tests of glaucoma patients who used trehalose and those who did not after primary trabeculectomy with mitomycin C (MMC) during the early postoperative period. Two groups were included in this analysis: Group 1 using Trehalose + hyaluronic acid (THA) after primary trabeculectomy with MMC (n = 19) and Group 2 undergoing primary trabeculectomy with MMC (n = 16). The preoperative and postoperative intraocular pressure (IOP), the consequences of Schirmer, and tear break-up time tests have been analyzed. There was no statistically significant difference between groups in preoperative IOP, Schirmer test, or tear break-up time. Trehalose use improved the surgical success of primary trabeculectomy with MMC in terms of IOP control, postoperative complications, and bleb morphology in the early postoperative period. Trehalose may aid in wound healing, resulting in an ideal bleb.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay